⌘K

Login Start Free

Home/Filings/4/0001855763-21-000013

4//SEC Filing

Downey Gregory 4

Accession 0001855763-21-000013

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 12:32 PM ET

Size

11.9 KB

Accession

0001855763-21-000013

Insider Transaction Report

Form 4

Period: 2021-05-07

Lexaria Bioscience Corp.LEXX

Chief Financial Officer

Transactions

Other
Stock Options
2021-05-07−8,000→ 17,000 total
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (8,000 underlying)

Holdings

Stock Options
Exercise: $5.04From: 2021-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
12,000
Stock Options
Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
20,000
common shares
1,833
Stock Options
Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
16,000
Stock Options
Exercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying)
25,000
Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (8,000 underlying)
8,000

Footnotes (1)

[F1]Cancelled Options

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001855801

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 12:32 PM ET
Size: 11.9 KB

View on SEC.gov